Compare
Medtronic plc vs Integer Holdings Corp vs LivaNova PLC vs Conmed Corp
| Latest fiscal year | Medtronic plc MDT | Integer Holdings Corp ITGR | LivaNova PLC LIVN | Conmed Corp CNMD |
|---|---|---|---|---|
| Year ended | 2026-04-24 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $36.36B | $1.85B | $1.39B | $1.37B |
| Revenue growth (YoY) | +8.4% | +8.0% | +10.7% | +5.2% |
| Gross margin | 65.0% (computed) | 27.0% | 67.7% (computed) | 54.6% |
| Operating margin | 17.8% | 11.9% | 14.4% | 7.5% |
| Net margin | 13.2% | 5.5% | -17.5% | 3.4% |
| Net income | $4.80B | $102.81M | -$242.47M | $47.05M |
| EPS (Diluted) | $3.73 | $2.89 | -$4.45 | $1.51 |
| Operating cash flow | $7.33B | $196.15M | $254.34M | $170.69M |
| Free cash flow | $5.43B | $105.12M | $173.29M | $150.88M |
| Cash & equivalents | $1.95B | $17.16M | $635.55M | n/a |
| Total assets | $93.03B | $3.41B | $2.61B | $2.33B |
| Total liabilities | $42.96B | $1.66B | $1.41B | $1.29B |
| Shareholders' equity | $49.46B | $1.75B | $1.20B | $1.03B |
| Return on year-end equity | 9.7% | 5.9% | -20.2% | 4.6% |
| Shares outstanding | 1.28B | 34.35M | 54.65M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Medtronic plc | Integer Holdings Corp | LivaNova PLC | Conmed Corp |
|---|---|---|---|---|
| Latest | $36.36B Ended 2026-04-24 | $1.85B Ended 2025-12-31 | $1.39B Ended 2025-12-31 | $1.37B Ended 2025-12-31 |
| 1 year earlier | $33.54B Ended 2025-04-25 | $1.72B Ended 2024-12-31 | $1.25B Ended 2024-12-31 | $1.31B Ended 2024-12-31 |
| 2 years earlier | $32.36B Ended 2024-04-26 | $1.56B Ended 2023-12-31 | $1.15B Ended 2023-12-31 | $1.24B Ended 2023-12-31 |
| 3 years earlier | $31.23B Ended 2023-04-28 | $1.33B Ended 2022-12-31 | $1.02B Ended 2022-12-31 | $1.05B Ended 2022-12-31 |
| 4 years earlier | $31.69B Ended 2022-04-29 | $1.22B Ended 2021-12-31 | $1.04B Ended 2021-12-31 | $1.01B Ended 2021-12-31 |